MedTrace Logo

Therapeutic Plasma Exchange in Resistant Cytokine Storm of COVID 19

NCT04457349 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2022-04-15

No results posted yet for this study

Summary

This research is planned to illustrate the efficacy of Therapeutic Plasma Exchange (TPE) treatment in COVID-19 patients with resistant cytokine storm state.

Conditions

  • COVID 19

Interventions

PROCEDURE

Therapeutic Plasma Exchange (TPE)

Treatment with Therapeutic Plasma Exchange (TPE)

Sponsors & Collaborators

  • Alexandria University

    lead OTHER

Principal Investigators

  • Mohamed Mamdouh Elsayed, MD · Lecturer of Nephrology & Internal Medicine, Faculty of Medicine, Alexandria university, Egypt

  • montasser M zeid, MD · Professor of Nephrology & Internal Medicine, Faculty of Medicine, Alexandria university, Egypt

  • Akram M Fayed, MD · Professor of Critical Care Medicine, Faculty of Medicine, Alexandria university, Egypt

  • Ehab M El Reweny, MD · Assistant Professor of Critical Care Medicine, Faculty of Medicine, Alexandria university, Egypt

  • Nermine H Zakaria, MD · Professor of Clinical and Chemical Pathology Medicine, Faculty of Medicine, Alexandria university, Egypt

  • Ayman I Baess, MD · Assistant Professor of Chest Diseases, Faculty of Medicine, Alexandria university, Egypt

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-25
Primary Completion
2020-12-29
Completion
2021-01-20

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04457349 on ClinicalTrials.gov